 | • レポートコード：MRC2312MG15399 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、76ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学＆材料 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のポリミキシンAPI市場規模と予測を収録しています。・世界のポリミキシンAPI市場：売上、2018年-2023年、2024年-2029年 ・世界のポリミキシンAPI市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のポリミキシンAPI市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ポリミキシンB」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ポリミキシンAPIのグローバル主要企業は、Xellia Pharmaceuticals ApS、 PharmaCompass、 Pharmaffiliates、 Fengchen Group、 Midas Pharma、 Caesar & Loretz GmbH、 LGM Pharma、 Beijing Mesochem Technology、 Hangzhou Zhongmei Huadong Pharmaceutical、 Yancheng Youhua Pharma and Chemical、 Livzon Pharmaceutical Group、 Lianyungang Runzhong Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ポリミキシンAPIのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のポリミキシンAPI市場：タイプ別、2018年-2023年、2024年-2029年 世界のポリミキシンAPI市場：タイプ別市場シェア、2022年 ・ポリミキシンB、ポリミキシンE、その他 世界のポリミキシンAPI市場：用途別、2018年-2023年、2024年-2029年 世界のポリミキシンAPI市場：用途別市場シェア、2022年 ・製薬会社、病院、科学研究機関、その他 世界のポリミキシンAPI市場：地域・国別、2018年-2023年、2024年-2029年 世界のポリミキシンAPI市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるポリミキシンAPIのグローバル売上、2018年-2023年 ・主要企業におけるポリミキシンAPIのグローバル売上シェア、2022年 ・主要企業におけるポリミキシンAPIのグローバル販売量、2018年-2023年 ・主要企業におけるポリミキシンAPIのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Xellia Pharmaceuticals ApS、 PharmaCompass、 Pharmaffiliates、 Fengchen Group、 Midas Pharma、 Caesar & Loretz GmbH、 LGM Pharma、 Beijing Mesochem Technology、 Hangzhou Zhongmei Huadong Pharmaceutical、 Yancheng Youhua Pharma and Chemical、 Livzon Pharmaceutical Group、 Lianyungang Runzhong Pharmaceutical ************************************************************* ・調査・分析レポートの概要 ポリミキシンAPI市場の定義 市場セグメント 世界のポリミキシンAPI市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のポリミキシンAPI市場規模 世界のポリミキシンAPI市場規模：2022年 VS 2029年 世界のポリミキシンAPI市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのポリミキシンAPIの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のポリミキシンAPI製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ポリミキシンB、ポリミキシンE、その他 ポリミキシンAPIのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：製薬会社、病院、科学研究機関、その他 ポリミキシンAPIの用途別グローバル売上・予測 ・地域別市場分析 地域別ポリミキシンAPI市場規模 2022年と2029年 地域別ポリミキシンAPI売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Xellia Pharmaceuticals ApS、 PharmaCompass、 Pharmaffiliates、 Fengchen Group、 Midas Pharma、 Caesar & Loretz GmbH、 LGM Pharma、 Beijing Mesochem Technology、 Hangzhou Zhongmei Huadong Pharmaceutical、 Yancheng Youhua Pharma and Chemical、 Livzon Pharmaceutical Group、 Lianyungang Runzhong Pharmaceutical ... |
This research report provides a comprehensive analysis of the Polymyxin API market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Polymyxin API market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Polymyxin API, challenges faced by the industry, and potential opportunities for market players.
The global Polymyxin API market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Polymyxin API market presents opportunities for various stakeholders, including Pharmaceutical Companies, Hospital. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Polymyxin API market. Additionally, the growing consumer demand present avenues for market expansion.
The global Polymyxin API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Polymyxin API market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Polymyxin API market.
Market Overview: The report provides a comprehensive overview of the Polymyxin API market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Polymyxin B, Polymyxin E), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Polymyxin API market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Polymyxin API market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Polymyxin API market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Polymyxin API market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Polymyxin API market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Polymyxin API market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Polymyxin API, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Polymyxin API market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Polymyxin API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Polymyxin B
Polymyxin E
Other
Market segment by Application
Pharmaceutical Companies
Hospital
Scientific Research Institutions
Other
Global Polymyxin API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Xellia Pharmaceuticals ApS
PharmaCompass
Pharmaffiliates
Fengchen Group
Midas Pharma
Caesar & Loretz GmbH
LGM Pharma
Beijing Mesochem Technology
Hangzhou Zhongmei Huadong Pharmaceutical
Yancheng Youhua Pharma and Chemical
Livzon Pharmaceutical Group
Lianyungang Runzhong Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Polymyxin API, market overview.
Chapter 2: Global Polymyxin API market size in revenue and volume.
Chapter 3: Detailed analysis of Polymyxin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Polymyxin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Polymyxin API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Polymyxin API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Polymyxin API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Polymyxin API Overall Market Size
2.1 Global Polymyxin API Market Size: 2022 VS 2029
2.2 Global Polymyxin API Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Polymyxin API Sales: 2018-2029
3 Company Landscape
3.1 Top Polymyxin API Players in Global Market
3.2 Top Global Polymyxin API Companies Ranked by Revenue
3.3 Global Polymyxin API Revenue by Companies
3.4 Global Polymyxin API Sales by Companies
3.5 Global Polymyxin API Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Polymyxin API Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Polymyxin API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Polymyxin API Players in Global Market
3.8.1 List of Global Tier 1 Polymyxin API Companies
3.8.2 List of Global Tier 2 and Tier 3 Polymyxin API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Polymyxin API Market Size Markets, 2022 & 2029
4.1.2 Polymyxin B
4.1.3 Polymyxin E
4.1.4 Other
4.2 By Type – Global Polymyxin API Revenue & Forecasts
4.2.1 By Type – Global Polymyxin API Revenue, 2018-2023
4.2.2 By Type – Global Polymyxin API Revenue, 2024-2029
4.2.3 By Type – Global Polymyxin API Revenue Market Share, 2018-2029
4.3 By Type – Global Polymyxin API Sales & Forecasts
4.3.1 By Type – Global Polymyxin API Sales, 2018-2023
4.3.2 By Type – Global Polymyxin API Sales, 2024-2029
4.3.3 By Type – Global Polymyxin API Sales Market Share, 2018-2029
4.4 By Type – Global Polymyxin API Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Polymyxin API Market Size, 2022 & 2029
5.1.2 Pharmaceutical Companies
5.1.3 Hospital
5.1.4 Scientific Research Institutions
5.1.5 Other
5.2 By Application – Global Polymyxin API Revenue & Forecasts
5.2.1 By Application – Global Polymyxin API Revenue, 2018-2023
5.2.2 By Application – Global Polymyxin API Revenue, 2024-2029
5.2.3 By Application – Global Polymyxin API Revenue Market Share, 2018-2029
5.3 By Application – Global Polymyxin API Sales & Forecasts
5.3.1 By Application – Global Polymyxin API Sales, 2018-2023
5.3.2 By Application – Global Polymyxin API Sales, 2024-2029
5.3.3 By Application – Global Polymyxin API Sales Market Share, 2018-2029
5.4 By Application – Global Polymyxin API Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Polymyxin API Market Size, 2022 & 2029
6.2 By Region – Global Polymyxin API Revenue & Forecasts
6.2.1 By Region – Global Polymyxin API Revenue, 2018-2023
6.2.2 By Region – Global Polymyxin API Revenue, 2024-2029
6.2.3 By Region – Global Polymyxin API Revenue Market Share, 2018-2029
6.3 By Region – Global Polymyxin API Sales & Forecasts
6.3.1 By Region – Global Polymyxin API Sales, 2018-2023
6.3.2 By Region – Global Polymyxin API Sales, 2024-2029
6.3.3 By Region – Global Polymyxin API Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Polymyxin API Revenue, 2018-2029
6.4.2 By Country – North America Polymyxin API Sales, 2018-2029
6.4.3 US Polymyxin API Market Size, 2018-2029
6.4.4 Canada Polymyxin API Market Size, 2018-2029
6.4.5 Mexico Polymyxin API Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Polymyxin API Revenue, 2018-2029
6.5.2 By Country – Europe Polymyxin API Sales, 2018-2029
6.5.3 Germany Polymyxin API Market Size, 2018-2029
6.5.4 France Polymyxin API Market Size, 2018-2029
6.5.5 U.K. Polymyxin API Market Size, 2018-2029
6.5.6 Italy Polymyxin API Market Size, 2018-2029
6.5.7 Russia Polymyxin API Market Size, 2018-2029
6.5.8 Nordic Countries Polymyxin API Market Size, 2018-2029
6.5.9 Benelux Polymyxin API Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Polymyxin API Revenue, 2018-2029
6.6.2 By Region – Asia Polymyxin API Sales, 2018-2029
6.6.3 China Polymyxin API Market Size, 2018-2029
6.6.4 Japan Polymyxin API Market Size, 2018-2029
6.6.5 South Korea Polymyxin API Market Size, 2018-2029
6.6.6 Southeast Asia Polymyxin API Market Size, 2018-2029
6.6.7 India Polymyxin API Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Polymyxin API Revenue, 2018-2029
6.7.2 By Country – South America Polymyxin API Sales, 2018-2029
6.7.3 Brazil Polymyxin API Market Size, 2018-2029
6.7.4 Argentina Polymyxin API Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Polymyxin API Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Polymyxin API Sales, 2018-2029
6.8.3 Turkey Polymyxin API Market Size, 2018-2029
6.8.4 Israel Polymyxin API Market Size, 2018-2029
6.8.5 Saudi Arabia Polymyxin API Market Size, 2018-2029
6.8.6 UAE Polymyxin API Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Xellia Pharmaceuticals ApS
7.1.1 Xellia Pharmaceuticals ApS Company Summary
7.1.2 Xellia Pharmaceuticals ApS Business Overview
7.1.3 Xellia Pharmaceuticals ApS Polymyxin API Major Product Offerings
7.1.4 Xellia Pharmaceuticals ApS Polymyxin API Sales and Revenue in Global (2018-2023)
7.1.5 Xellia Pharmaceuticals ApS Key News & Latest Developments
7.2 PharmaCompass
7.2.1 PharmaCompass Company Summary
7.2.2 PharmaCompass Business Overview
7.2.3 PharmaCompass Polymyxin API Major Product Offerings
7.2.4 PharmaCompass Polymyxin API Sales and Revenue in Global (2018-2023)
7.2.5 PharmaCompass Key News & Latest Developments
7.3 Pharmaffiliates
7.3.1 Pharmaffiliates Company Summary
7.3.2 Pharmaffiliates Business Overview
7.3.3 Pharmaffiliates Polymyxin API Major Product Offerings
7.3.4 Pharmaffiliates Polymyxin API Sales and Revenue in Global (2018-2023)
7.3.5 Pharmaffiliates Key News & Latest Developments
7.4 Fengchen Group
7.4.1 Fengchen Group Company Summary
7.4.2 Fengchen Group Business Overview
7.4.3 Fengchen Group Polymyxin API Major Product Offerings
7.4.4 Fengchen Group Polymyxin API Sales and Revenue in Global (2018-2023)
7.4.5 Fengchen Group Key News & Latest Developments
7.5 Midas Pharma
7.5.1 Midas Pharma Company Summary
7.5.2 Midas Pharma Business Overview
7.5.3 Midas Pharma Polymyxin API Major Product Offerings
7.5.4 Midas Pharma Polymyxin API Sales and Revenue in Global (2018-2023)
7.5.5 Midas Pharma Key News & Latest Developments
7.6 Caesar & Loretz GmbH
7.6.1 Caesar & Loretz GmbH Company Summary
7.6.2 Caesar & Loretz GmbH Business Overview
7.6.3 Caesar & Loretz GmbH Polymyxin API Major Product Offerings
7.6.4 Caesar & Loretz GmbH Polymyxin API Sales and Revenue in Global (2018-2023)
7.6.5 Caesar & Loretz GmbH Key News & Latest Developments
7.7 LGM Pharma
7.7.1 LGM Pharma Company Summary
7.7.2 LGM Pharma Business Overview
7.7.3 LGM Pharma Polymyxin API Major Product Offerings
7.7.4 LGM Pharma Polymyxin API Sales and Revenue in Global (2018-2023)
7.7.5 LGM Pharma Key News & Latest Developments
7.8 Beijing Mesochem Technology
7.8.1 Beijing Mesochem Technology Company Summary
7.8.2 Beijing Mesochem Technology Business Overview
7.8.3 Beijing Mesochem Technology Polymyxin API Major Product Offerings
7.8.4 Beijing Mesochem Technology Polymyxin API Sales and Revenue in Global (2018-2023)
7.8.5 Beijing Mesochem Technology Key News & Latest Developments
7.9 Hangzhou Zhongmei Huadong Pharmaceutical
7.9.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Summary
7.9.2 Hangzhou Zhongmei Huadong Pharmaceutical Business Overview
7.9.3 Hangzhou Zhongmei Huadong Pharmaceutical Polymyxin API Major Product Offerings
7.9.4 Hangzhou Zhongmei Huadong Pharmaceutical Polymyxin API Sales and Revenue in Global (2018-2023)
7.9.5 Hangzhou Zhongmei Huadong Pharmaceutical Key News & Latest Developments
7.10 Yancheng Youhua Pharma and Chemical
7.10.1 Yancheng Youhua Pharma and Chemical Company Summary
7.10.2 Yancheng Youhua Pharma and Chemical Business Overview
7.10.3 Yancheng Youhua Pharma and Chemical Polymyxin API Major Product Offerings
7.10.4 Yancheng Youhua Pharma and Chemical Polymyxin API Sales and Revenue in Global (2018-2023)
7.10.5 Yancheng Youhua Pharma and Chemical Key News & Latest Developments
7.11 Livzon Pharmaceutical Group
7.11.1 Livzon Pharmaceutical Group Company Summary
7.11.2 Livzon Pharmaceutical Group Business Overview
7.11.3 Livzon Pharmaceutical Group Polymyxin API Major Product Offerings
7.11.4 Livzon Pharmaceutical Group Polymyxin API Sales and Revenue in Global (2018-2023)
7.11.5 Livzon Pharmaceutical Group Key News & Latest Developments
7.12 Lianyungang Runzhong Pharmaceutical
7.12.1 Lianyungang Runzhong Pharmaceutical Company Summary
7.12.2 Lianyungang Runzhong Pharmaceutical Business Overview
7.12.3 Lianyungang Runzhong Pharmaceutical Polymyxin API Major Product Offerings
7.12.4 Lianyungang Runzhong Pharmaceutical Polymyxin API Sales and Revenue in Global (2018-2023)
7.12.5 Lianyungang Runzhong Pharmaceutical Key News & Latest Developments
8 Global Polymyxin API Production Capacity, Analysis
8.1 Global Polymyxin API Production Capacity, 2018-2029
8.2 Polymyxin API Production Capacity of Key Manufacturers in Global Market
8.3 Global Polymyxin API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Polymyxin API Supply Chain Analysis
10.1 Polymyxin API Industry Value Chain
10.2 Polymyxin API Upstream Market
10.3 Polymyxin API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Polymyxin API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
